IT services and products firm Infosys is set to acquire Kaleidoscope Innovation, a product design and development firm that operates in medical, consumer and industrial markets.
Infosys will pay $42 million for acquiring 100 per cent stake in the Cincinnati-headquartered company and the amount includes earn-out, management incentives and bonuses, according to the exchange filing. The acquisition is expected to shut all over the second one quarter of fiscal 2021, subject to customary closing conditions.
The Bengaluru-based firm said the acquisition demonstrates the company’s commitment to innovate for its clients, and make a meaningful have an effect on on human lives by combining state of the art technologies and experiences to revolutionise patient care, remedy, diagnostics and consumer health globally.
ALSO READ: Tata Motors starts Q2 on strong note, riding on passenger vehicles sales
“This acquisition further strengthens our digital offerings at the intersection of new software technologies and medical devices – a sector that is expected to witness remarkable investments and consumerisation in the post-Covid era,” said Ravi Kumar, President, Infosys. “Our clients will have the benefit of the combination of Kaleidoscope’s strong upstream offerings of product innovation and design, and Infosys’ stack of product engineering, validation and commercialisation services and products at a global scale.”
“We are enthusiastic approximately our exciting new partnership with Infosys. It allows us to scale quickly and bring expanded offerings in AI, Analytics, and Digital Infrastructure to our clients. Kaleidoscope has all the time valued the ability to fortify people’s lives and their outcomes through innovation,” said Matt Kornau, CEO & co-founder at Kaleidoscope Innovation.